Daiichi Sankyo Investor Relations Material
Latest events
Q2 2025
Daiichi Sankyo
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Daiichi Sankyo Company Limited
Access all reports
Daiichi Sankyo Company Limited is a global pharmaceutical company, focusing on the research, development, manufacturing, and marketing of pharmaceutical products. The company operates in the healthcare sector, providing drugs and services in various therapeutic areas, including cardiovascular, oncology, and metabolic disorders, among others. Daiichi Sankyo's approach combines expertise in biologics with advanced research technologies to develop novel therapies and solutions for patients worldwide. The company is headquartered in Tokyo, Japan, and its shares are listed on the Tokyo Stock Exchange.
Key slides for Daiichi Sankyo Company Limited
Q3 2024
Daiichi Sankyo Company Limited
Q3 2024
Daiichi Sankyo Company Limited
Latest articles
Lessons from Gautam Baid: Mastering Simplicity and Compounding
Gautam Baid's journey of compounding wisdom, investing simplicity, and lifelong learning – insights to transform your financial and personal growth.
13 Dec 2024
Rocket Lab: Breaking Ground in Space
Rocket Lab has been one of the pioneers in the commercial aerospace industry, with numerous satellite launches and space system applications.
9 Dec 2024
Anthony Noto: The Multifaceted CEO of SoFi
Anthony Noto built a successful and diverse career across multiple industries before becoming CEO of the fintech company SoFi.
9 Dec 2024
Ticker symbol
4568
Country
🇯🇵 Japan